HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity.

Abstract
We introduce a new category of nanoparticle-based T(1) MRI contrast agents (CAs) by encapsulating paramagnetic chelated gadolinium(III), i.e., Gd(3+)·DOTA, through supramolecular assembly of molecular building blocks that carry complementary molecular recognition motifs, including adamantane (Ad) and β-cyclodextrin (CD). A small library of Gd(3+)·DOTA-encapsulated supramolecular nanoparticles (Gd(3+)·DOTA⊂SNPs) was produced by systematically altering the molecular building block mixing ratios. A broad spectrum of relaxation rates was correlated to the resulting Gd(3+)·DOTA⊂SNP library. Consequently, an optimal synthetic formulation of Gd(3+)·DOTA⊂SNPs with an r(1) of 17.3 s(-1) mM(-1) (ca. 4-fold higher than clinical Gd(3+) chelated complexes at high field strengths) was identified. T(1)-weighted imaging of Gd(3+)·DOTA⊂SNPs exhibits an enhanced sensitivity with a contrast-to-noise ratio (C/N ratio) ca. 3.6 times greater than that observed for free Gd(3+)·DTPA. A Gd(3+)·DOTA⊂SNPs solution was injected into foot pads of mice, and MRI was employed to monitor dynamic lymphatic drainage of the Gd(3+)·DOTA⊂SNPs-based CA. We observe an increase in signal intensity of the brachial lymph node in T(1)-weighted imaging after injecting Gd(3+)·DOTA⊂SNPs but not after injecting Gd(3+)·DTPA. The MRI results are supported by ICP-MS analysis ex vivo. These results show that Gd(3+)·DOTA⊂SNPs not only exhibits enhanced relaxivity and high sensitivity but also can serve as a potential tool for diagnosis of cancer metastasis.
AuthorsKuan-Ju Chen, Stephanie M Wolahan, Hao Wang, Chao-Hsiung Hsu, Hsing-Wei Chang, Armando Durazo, Lian-Pin Hwang, Mitch A Garcia, Ziyue K Jiang, Lily Wu, Yung-Ya Lin, Hsian-Rong Tseng
JournalBiomaterials (Biomaterials) Vol. 32 Issue 8 Pg. 2160-5 (Mar 2011) ISSN: 1878-5905 [Electronic] Netherlands
PMID21167594 (Publication Type: Evaluation Study, Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • Chelating Agents
  • Contrast Media
  • Heterocyclic Compounds, 1-Ring
  • 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
  • Gadolinium
Topics
  • Animals
  • Chelating Agents (chemistry)
  • Contrast Media (chemistry)
  • Gadolinium (chemistry)
  • Heterocyclic Compounds, 1-Ring (chemistry)
  • Magnetic Resonance Imaging (methods)
  • Materials Testing
  • Mice
  • Nanoparticles (chemistry)
  • Particle Size
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: